NDC 67877-540

Temozolomide 140 mg capsule

On the label: Ascend Laboratories, LLC.

Where it's made

Recalls

• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: a) A062238, A062118, A062115, A062112, A062100, Exp 08/31/2019; A068946, Exp 04/30/2020; A071733, Exp 09/30/2020; b) A062194, A062181, A62275, A062218, Exp 08/31/2019; A069154, Exp 04/30/2020; A071734, A071783, A071735, Exp 09/30/2020
• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: a) A061688, A061687, A061685, Exp 07/31/2019; A068994, Exp 04/30/2020; A071853, Exp 09/30/20; b) A061794, A061833, A061822, Exp 07/31/2019; A069115, Exp 04/30/2020; A071855, A071854, Exp 09/30/2020
• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: a) A061783, A061782, A061781, Exp 07/31/2019; A069128, Exp 05/31/2020; A071923, Exp 09/30/20; b) A061874, A061861, A061896, Exp 07/31/2019; A069326, Exp 05/31/2020; A071924, A071977, A071925, Exp 09/30/2020
• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: a) A063581, A063462, A063460, Exp 09/30/2019; A063582, Exp 10/31/2019; A069129, Exp 05/31/2020; A071801, Exp 09/30/2020; b) A063639, A063624, A063609, Exp 09/30/2019; A063657, Exp 10/31/2019; A069366, Exp 05/31/2020; A071817, A071819, A071818, Exp 09/30/2020
• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: a) A061858, A061857, A061856, A061860, A061859, Exp 07/31/2019; A069401, A069402, Exp 05/31/2020; A071978, Exp 09/30/2020; A076736, A076735, Exp 04/30/2021; b) A062031. A062015, A062014, A062050, A062038, Exp 07/31/2019; A069521, A069470, Exp 05/31/2020; A071979, A072014, A072013, Exp 09/30/…
• Jul 16, 2019 · Class II · Deva Holding AS - Cerkezkoy Subesi
  CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.
  Lots: Lot #: A062228, A062227, A062226, A062295, A062294, Exp 08/31/2019; A069325, A069323, Exp 05/31/2020; A072015, Exp 10/31/2020; A076611, A076609, A076608, A076607, Exp 04/30/2021

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Temozolomide: every company that makes it

Form

capsule, oral

Strength

140 mg

Approval

ANDA ANDA207658

On the market since

Apr 28, 2017

Package NDCs

67877-540-07 67877-540-14

Official label

DailyMed (National Library of Medicine), updated Jan 9, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?